Myriad Genetics, Inc. ( MYGN ) is currently at $4.64, down $2.63 or 36.18%
--Would be lowest close since March 17, 2003, when it closed at $4.57
--On pace for largest percent decrease since Nov. 5, 2019, when it fell 40.37%
--Currently down two consecutive days; down 39.74% over this period
--Worst two day stretch since the two days ending Aug. 15, 2019, when it fell 47.92%
--Down 37.38% month-to-date
--Down 66.16% year-to-date
--Down 92.43% from its all-time closing high of $61.27 on Nov. 6, 2000
--Down 80.63% from 52 weeks ago (May 8, 2024), when it closed at $23.95
--Down 83.78% from its 52-week closing high of $28.60 on Sept. 17, 2024
--Would be a new 52-week closing low
--Traded as low as $4.60; lowest intraday level since March 17, 2003, when it hit $4.41
--Down 36.73% at today's intraday low; largest intraday percent decrease since Nov. 5, 2019, when it fell as much as 42.74%
All data as of 11:47:18 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 07, 2025 11:54 ET (15:54 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。